Exon 3 of the α folate receptor gene contains a 5′ splice site which confers enhanced ovarian carcinoma specific expression

Enrico Galmozzi, Antonella Tomassetti, Sabrina Sforzini, Fabio Mangiarotti, Mimma Mazzi, Kiki Nachmanoff, Patrick C. Elwood, Silvana Canevari

Research output: Contribution to journalArticle

Abstract

The human folate receptor (FR) is overexpressed in ovarian carcinoma. FR transcripts are heterogeneous due to the use of two promoters, P1 and P4, and alternative splicing of exon 3. RNase protection assay and RT-PCR revealed higher levels of the transcripts that include exon 3 in lines and specimens from ovarian carcinoma. A P1-chloramphenicol acetyltransferase (CAT) construct containing exon 3 demonstrated efficient reporter expression only in ovarian carcinoma. 5′ and 3′ deleted variants of the P1-CAT construct were analyzed by RT-PCR of the exogenous transcripts and reporter activity. A 5′ splice site and 35 bp downstream intronic region of exon 3 appeared to regulate enhanced FR expression in ovarian carcinoma.

Original languageEnglish
Pages (from-to)31-34
Number of pages4
JournalFEBS Letters
Volume502
Issue number1-2
DOIs
Publication statusPublished - Jul 27 2001

Keywords

  • α Folate receptor
  • Alternative splicing
  • Gene therapy
  • Ovarian carcinoma
  • Transcription regulation

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Fingerprint Dive into the research topics of 'Exon 3 of the α folate receptor gene contains a 5′ splice site which confers enhanced ovarian carcinoma specific expression'. Together they form a unique fingerprint.

  • Cite this